Navigation Links
Dow Agrosciences licenses exclusive novel crop enhancement technology
Date:11/2/2010

The John Innes Centre is pleased to announce an exclusive commercial license agreement for technology that enhances the root systems of plants and with important implications for crop improvement. JIC's technology management company Plant Bioscience Limited (PBL) is licensing the technology to Dow AgroSciences.

Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), entered into an exclusive commercial license agreement with Plant Bioscience Limited (PBL) for technology that enhances the root systems of plants with important implications for crop improvement. The commercial license covers a range of important agricultural crops.

The technology was developed by Dr. Liam Dolan and his colleagues at the John Innes Centre, an institute of the BBSRC on the Norwich Research Park. With BBSRC funding, the team cloned and characterized genes which may play vital roles in anchorage, water use and nutrient uptake in plants. The genes are highly conserved among land plants and the technology has already been shown to be effective in enhancing root systems in transgenic plants of major crops around the world.

"Our research aims to answer key questions in biology and to provide solutions to important problems in food security, energy production, promoting health and combating disease," said Professor Dale Sanders, Director of the John Innes Centre. "The technology was born out of basic research in nutrient uptake by plants and demonstrates the importance to agriculture of answering fundamental questions."

"Dow AgroSciences is excited to be collaborating with one of the most respected organizations in the biotechnology industry," said Dan Kittle, Ph.D., vice president of Dow AgroSciences. "By combining our expertise in biotech crops and PBL's innovative technology from JIC, we have the opportunity to enhance a plant's ability to survive stress, increase nutrient utilization, and provide yield stability in challenging years or
'/>"/>

Contact: Zoe Dunford
zoe.dunford@bbsrc.ac.uk
44-016-032-55111
Norwich BioScience Institutes
Source:Eurekalert

Page: 1 2

Related biology news :

1. Ocera Therapeutics licenses novel treatment for acute hepatic encephalopathy from UCLB
2. UGA licenses invention that kills food-borne pathogens in minutes
3. UGA licenses new Bermuda grass that thrives in sun and shade
4. UGA licenses technology to make fuel from dead forests and agricultural waste
5. MSU licenses plant oil enhancement technology to BASF Plant Science
6. TAXIS Pharmaceuticals licenses novel antimicrobial technology from Rutgers and UMDNJ
7. UT-Battelle licenses tissue regeneration technologies to NellOne Therapeutics, Inc.
8. Virginia Tech licenses GenoCAD source code to ISCB
9. UC Riverside licenses technology to OlFactor Laboratories, Inc.
10. U of M licenses unique plant protection product
11. Brown licenses potential muscular dystrophy treatment to Tivorsan Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/sxwl43/global_2d_gesture ) ... 2D Gesture Recognition Market 2015-2019" report to ... the Global 2D Gesture Recognition market to grow ... 2014-2019 The increased demand for gesture-enabled ... the major trends in the market. The growing ...
(Date:2/12/2015)... 2015   MedNet Solutions , a global ... management systems, has recently bolstered its ... iMedNet as the eClinical solution ... healthcare consultants.  Building on the Program,s existing benefits ... numerous co-marketing opportunities), MedNet,s new and improved program ...
(Date:2/5/2015)... , 5. Februar 2015 ... spezialisiertes Logistikunternehmen und hat eine neue Marketingkampagne ... Logistikfirma (Clinical Logistics Organization – CLO) der ... Kampagne lautet First , mit Schwerpunkt ... Foto: http://photos.prnewswire.com/prnh/20150205/173753 Logo ...
Breaking Biology News(10 mins):Global 2D Gesture Recognition Market 2015-2019 with Cognitec Systems, CogniVue, eyeSight Mobile Technologies & PointGrab Dominating 2MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3
... with intelligence as a beneficial trait, according to ... Medical Center and other institutions. Jeremy Coplan, MD, ... found that high intelligence and worry both correlate ... the nutrient choline in theGlaxoSmithKline Pharmaceuticals, Sackler Institute ...
... Scientists at the Allen Institute for Brain Science have identified ... the brains of human individuals, and between humans and mice ... brain. The study, published online today in the journal ... and also serves as an introduction to what the associated ...
... - - Finger Vein Identity Management ... - - Hitachi Europe Ltd. and M2SYS ... partnership making M2SYS Hitachi,s primary Value Added Reseller in North ... Biometric Finger Vein identity management scanning technology was developed by ...
Cached Biology News:Excessive worrying may have co-evolved with intelligence 2Fine-scale analysis of the human brain yields insight into its distinctive composition 2Fine-scale analysis of the human brain yields insight into its distinctive composition 3M2SYS Technology Partners with Hitachi to Offer Innovative Biometric Finger Vein Scanner to US Market 2
(Date:3/3/2015)... N.J. , March 3, 2015  Regenicin, Inc. ... company specializing in the development of and commercialization of ... tissues and organs, announced today that it has received ... with Amarantus Bioscience Holdings, Inc. (OTC Bulletin Board: ... the Agreement, Amarantus made the final payments due to ...
(Date:3/3/2015)... 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" ... Expert Opinion on Biological Therapy , Dr. ... Zhang , at the Henry Ford Hospital in ... 4 (TB4) has the capacity to promote CNS and ... post-injury, leading to neurological recovery in each case.  They ...
(Date:3/3/2015)... -- Kindred Biosciences, Inc. (NASDAQ: KIN ), a ... pets, announced today that it will release its fourth quarter ... the market close. The Company will host a conference call ... Interested parties may access the call by dialing toll-free (855) ... conference ID 98449349.  The call will also ...
(Date:3/3/2015)... 03, 2015 Research and Markets ... Jain PharmaBiotech,s new report "Personalized Medicine - ... , The aim of personalized ... right drug to the right patient and, in ... for a patient according to his/her genotype. This ...
Breaking Biology Technology:Regenicin (RGIN) Receives $2.3 Million in Final Payment from Amarantus 2Regenicin (RGIN) Receives $2.3 Million in Final Payment from Amarantus 3Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 2Researchers at Henry Ford Hospital Propose Thymosin Beta 4 as Novel Way to Treat Neural Injury and Neurodegenerative Diseases 3Global Personalized Medicine Market Report 2015 - Scientific and Commercial Aspects 2014-2024 2Global Personalized Medicine Market Report 2015 - Scientific and Commercial Aspects 2014-2024 3
... Jan. 27 Alfacell Corporation (OTC Bulletin Board: ACEL) ... with the U.S. Food and Drug Administration (FDA) to ... of the ONCONASE rolling New Drug Application (NDA) for ... At the pre-NDA meeting, the FDA provided guidance to ...
... RELY ON INFORMATION PUBLISHED BY UNIVERSAL , NETTLETON, ... Sheets: UBRG) announces that certain unauthorized inaccurate information ... report on BeaconEquity.com website, potentially other websites and ... these materials, the company has found errors in ...
... Webcast Scheduled for Tuesday, February 3, 2009 SAN DIEGO, ... NBIX ) announced today that the Company will report ... the Nasdaq market closes on Tuesday, February 3, 2009. ... webcast to discuss its financial results and provide a ...
Cached Biology Technology:Alfacell Provides ONCONASE(R) NDA Submission Update 2Alfacell Provides ONCONASE(R) NDA Submission Update 3Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year End 2008 Financial Results 2
Auto/Zyme Reagent...
4',6-Diamidino-2-phenylindole dihydrochloride...
...
Normal Bovine Serum; U.S. sourced, ideal for those who seek an uncompromising quality. Low Hemoglobin levels; U.S. sourced, ideal for those who seek an uncompromising quality. Low Hemoglobin lev...
Biology Products: